Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DJ.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DJ.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DJ.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DJ.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DJ.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DJ.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XBC.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBC.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBC.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBC.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.11.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.11.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.11.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.11.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.11.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EE.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EE.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EE.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EE.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EE.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EE.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.52EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.52ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.52ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.52EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.52EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBF.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBF.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used